Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

Estabulari

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit
Funding agency: Instituto de Salud Carlos III
Funding: 99000
Reference: CA10/01489
Duration: 01/01/2011 - 22/04/2014

Papel del sistema nervioso simpático en la génesis y mantenimiento de las alteraciones hemodinámicas (vasodilatación mesentérica) de la hipertensión portal (SIMPATHAL)

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 84700
Reference: SAF2009-08354
Duration: 01/01/2010 - 31/12/2012

Ministerio de Ciencia

Estudio multicéntrico, aleatorizado, doble-ciego, controlado con placebo, sobre la eficacia del tratamiento con beta-bloqueantes para pevenir la descompensación de la cirrosis con hipertensión portal

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: EC08/00070
Duration: 01/01/2009 - 30/06/2013

Papel del sistema nervioso simpático en la génesis y mantenimiento de las alteraciones hemodinámicas (vasodilatación mesentérica) de la hipertensión portal.

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13500
Reference: PRED/IR-HUVH/13/2008
Duration: 01/01/2009 - 31/12/2012

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Albert Barberà LLuis

Albert Barberà LLuis

Director/a d'Àrea
External Strategy Directorate
Read more
Judit Amigó Farran

Judit Amigó Farran

Predoctoral researcher
Diabetes and Metabolism
Read more
Alba Rojano Toimil

Alba Rojano Toimil

Predoctoral researcher
Diabetes and Metabolism
Read more
Neus Mongay Ochoa

Neus Mongay Ochoa

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.